knowledge -WSS

knowledge

author：leisure time 2025-08-25 06:01:21 - browse：7717

Today, if you want to know what scary family health secrets lay buried in your DNA or get screened for a lurking cancer, you have a lot of options. Laboratories have developed more than 75,000 genetic tests, with about 10 new ones entering the market daily. By the end of 2019, more than 26 million Americans had had their DNA decoded to some degree or another. Since then, that number has surely grown.

But this testing frenzy would have been inconceivable just 10 years ago. In part, that’s because the technology back then was so expensive. More importantly, until 2013, it was common practice for gene-hunting academics and companies to lock up their discoveries with DNA patents, effectively carving up the human genome into mini-monopolies. That year, the U.S. Supreme Court threw a bomb into the biotech world when it took up a landmark case that pitted cancer survivors and the American Civil Liberties Union against a diagnostics company called Myriad Genetics, which had obtained exclusive patents on the cancer-causing BRCA genes and made billions of dollars selling tests for them.

A new book called “The Genome Defense,” written by University of Utah science and technology law expert Jorge Contreras and being published Oct. 26, provides a front-row seat to the courtroom drama that would upend three decades of federal intellectual property law and chart a new course toward balancing corporate profits with the rights of all people to the information written into their DNA.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Life science postdocs should get big pay hike, NIH panel says

WSS

Nonprofit, backed by Microsoft, to certify AI tools in health care

Heat waves linked to early deliveries, preterm births in new study

Startling documents reveal new facets of Sacklers' opioid empire

Startling documents reveal new facets of Sacklers' opioid empire

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

focus

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

Insmed lung disease drug hits target in key Phase 3 trial

George Santos makes 1st court appearance after pleading not guilty to 13 counts

What will save rural psychiatry services? Higher Medicaid payments

Malaria cases in Florida and Texas: Here’s what you need to know

STAT Virtual Event: JPM Recap, Live!

In age of alternative facts, a scholarly course on calling out crap

American taxpayers paid $1.8 trillion in health care costs in 2022

Wildfire smoke exposes gaps in outdoor worker protections

Medicare Advantage coverage denials need scrutiny, senators say

leisure time

STAT Virtual Event: JPM Recap, Live!

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Heat waves linked to early deliveries, preterm births in new study

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

At JPM 2024, hospital systems pitch financial strength to investors

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

hotspot

explore

Wikipedia

hotspot